Protenium Clinical Research /ID# 244067 — Hurst, Texas

Protenium Clinical Research /ID# 244067 is a clinical research site located in Hurst, Texas, United States 76054.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Protenium Clinical Research /ID# 244067 has participated in 1 clinical trials.

Therapeutic areas: Episodic Migraine.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hurst

Browse all research sites in Texas · View every site in Hurst

• Protenium Clinical Research
• Novo Nordisk Investigational Site
• GSK Investigational Site
• Research Site
• Texas Eye and Laser Center
• Pfizer Investigational Site
• Texas Eye Research Center
• BioSante Site 154
• Ventavia Research Group
• Texas Familicare Clinical Research
• Texas Eye & Laser Center, P.A.
• Texas Eye & Laser Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Protenium Clinical Research /ID# 244067?

Protenium Clinical Research /ID# 244067 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Protenium Clinical Research /ID# 244067 conducted?

Protenium Clinical Research /ID# 244067 has 1 clinical trials on record. Their work covers Episodic Migraine.

Is Protenium Clinical Research /ID# 244067 accredited by Crixeo Clinical Trials?

Protenium Clinical Research /ID# 244067 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Protenium Clinical Research /ID# 244067?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.